Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release.
about
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell VaccinesTargeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future PerspectivesThe Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacyRose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cellsImmunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationImmune-associated proteins with potential in�vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approachCeramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposureHMGB1 in health and disease.Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity.Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.Combinatorial strategies for the induction of immunogenic cell death.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.New photodynamic therapy with next-generation photosensitizers.Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.Photodynamic therapy: oncologic horizons.ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.Autophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy.Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy.Calreticulin, a therapeutic target?Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer?α-Integrin expression and function modulates presentation of cell surface calreticulin.HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer.Calreticulin as cancer treatment adjuvant: combination with photodynamic therapy and photodynamic therapy-generated vaccines.Trial watch: Chemotherapy with immunogenic cell death inducers.Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
P2860
Q26772715-0A5517B0-9EDE-438B-921B-C5DB5DB6C86BQ28066286-BCE28141-6567-4960-8A89-D75BEB6A2A01Q28076473-204A405A-396E-4020-8BC8-B4F55B4742CBQ28246367-A2279035-854B-454E-89C0-AE6C9ED98DA0Q28386858-D9F25B0E-CC06-4F0C-A447-8133E52CB6BEQ28468345-943EAD96-6947-4F84-A539-DB55219585F2Q33705468-FAAB31AA-42FF-49F9-90FB-6946A7A345DDQ34622835-996C5CF7-5036-41D0-9C41-C62BC4DEFB47Q35025948-13F42C45-C8B8-41CD-A807-1ADBD1BC7B22Q35123212-8F9FFD84-AC5D-4F38-8D1D-B087FBAF1BFEQ35535140-362DAA40-EB6B-41E2-ABE9-F10B2E8DA958Q36301061-B2B904D3-419A-483D-8C59-20EC8EF44CBCQ36405909-1698F8CB-6C67-405A-856A-BCB3B6A95111Q37565103-094D94D8-EC4A-44DC-A0F7-9C3740A171C6Q37634941-AE2EDD95-D9C4-4EE2-A334-5815FE6EB8C0Q38170385-0EBF0E43-A36B-42A6-A2A7-C7F7985E4775Q38184935-AA3E8210-DA21-43CE-ABE0-E07047E6096AQ38202871-A4B4E467-6C8C-46E7-9823-F49D585E0FCAQ38349813-14D900C1-512F-4155-AFC6-AA4E5A4F6FA9Q38766974-356580E2-68A0-41F5-9200-53A050C24A9CQ39178654-3F36CA8B-5161-4534-91B5-DC43217F7EDFQ42013881-A03EA056-7406-40B0-B7AC-A82B62583C49Q42540208-46183F42-7AFE-48DC-8D99-FA9785DA251FQ43129014-0467FFA2-0539-478A-BC4F-CF9A3564ACF7Q55658029-3ADD161E-CAD7-4CD5-AEA1-D907DF715CC6Q58032919-2752161A-FB90-4342-9A63-73A800897867
P2860
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Involvement of damage-associat ...... -mobility group box-1 release.
@en
Involvement of damage-associat ...... -mobility group box-1 release.
@nl
type
label
Involvement of damage-associat ...... -mobility group box-1 release.
@en
Involvement of damage-associat ...... -mobility group box-1 release.
@nl
prefLabel
Involvement of damage-associat ...... -mobility group box-1 release.
@en
Involvement of damage-associat ...... -mobility group box-1 release.
@nl
P2093
P2860
P1476
Involvement of damage-associat ...... -mobility group box-1 release.
@en
P2093
Mladen Korbelik
Soroush Merchant
P2860
P2888
P304
P356
10.1007/S00262-011-1047-X
P577
2011-06-05T00:00:00Z